Cumberland Pharmaceuticals Inc (NASDAQ: CPIX) stock enjoyed a major increase of 15.2% on 10/7/25. The shares closed at $3.56. Moreover, unusually high trading volume at 170% of normal accompanied the advance. The stock has been weak relative to the market over the last nine months but has risen 12.7% during the last week.
Current PriceTarget Research Rating
Cumberland Pharmaceuticals has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Cumberland Pharmaceuticals has a poor Power Rating of 22 and a very low Appreciation Score of 14, and the Lowest Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment